iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis

Yanhong Li*, Wei Sun, Bao jin Zhou, Adam Rosenstein, Jie Zhao, Jian Wang, Zhaoxiang Bian

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis'. Together they form a unique fingerprint.

Medicine & Life Sciences